Further to my research and clinical activities, as President of the World Federation of
Nuclear Medicine and Biology, the peak global Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA a
Nuclear Medicine and Biology, the peak global Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA
Medicine and Biology, the peak global
Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA a
Nuclear Medicine organisation, I am engaged in strategic planning for training, health care policy, and advocacy for molecular imaging and nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA
Medicine organisation, I am engaged
in strategic planning for
training, health care policy, and advocacy for molecular imaging and
nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA a
nuclear medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA
medicine therapy within the US, European, South American, Asia - Oceania, and African regions, and with the IAEA and WHO.